🔎 Trials Near Me

Akèy › Neuromyelitis Optica › Massachusetts

Etid klinik pou Neuromyelitis Optica nan Massachusetts

5 etid pou Neuromyelitis Optica ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  • Research Site, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05966467

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

  • Research Site, Boston
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Apr 16, 2026 · NCT06312644

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

  • Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 2 a 17 · Tout sèks · Mizajou Dec 5, 2025 · NCT05549258

Efgartigimod for the Treatment of Acute Optic Neuritis

  • Massachusetts Eye and Ear Infirmary, Boston
  • Massachusetts General Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06453694

Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD

  • Massachussets General Hospital, Boston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 10, 2025 · NCT05566769

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.